DUBLIN, Ireland, Oct. 23 /PRNewswire-FirstCall/ -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2008 on Friday, October 31, 2008. The Company has scheduled a conference call for that same day, Friday, October 31, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.
About Trinity Biotech plc
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.
CONTACT: Ms. Niamh Long, Trinity Biotech plc Investor Relations Officer,
1-800-603-8076; or Joe Diaz, Joe Dorame or Robert Blum, all of Lytham
Partners, LLC, +1-602-889-7900, for Trinity Biotech plc
Web site: http://www.trinitybiotech.com/
